Kidney Stone Market – Overview
Global Kidney Stone Market is expecting a growth of 4% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR). Their published report has its focus on segmental analysis, and factors that can impact the market in the foreseeable future. Among the major factors, increasing adoption of the industry-based life and approval of urban ways have squarely inspired a spurt in cases related to urolithiasis. In addition, diabetes and kidney stone are diseases that grow in tandem, and diabetes is one of the most prevalent diseases in the world which gives a glimpse of possibilities for the kidney stone market in the coming years. At the same time, minimally invasive surgeries are becoming a trend and they are cost-effective which makes people rely on it more than before.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1745
On the downside, extracorporeal shock wave lithotripsy can cause hypertension deterring the kidney stone market prospect during the forecast period. But a long slumber cannot be expected as other therapies can steer the kidney stone market out of any further damage.
The Kidney Stone Market is creating quite a ripple owing to the technological advancements it has seen over the years. This advancement has made treatments more impactful, and the permeation of healthcare has eased the integration process of the kidney stone sector across social strata, inflating the market in the process. The medicinal and engineering leaps the industry has taken in over the decades made the diagnosis easier and treatment more reliable.
The global kidney stone market can be segmented by type, treatment, and diagnosis.
Based on type, the kidney stone market can be segmented into calcium stones, uric acid, struvite kidney stones, and cystine stones. Calcium stones segment can go up to USD 1,561.7 million by 2022. At present, it covers almost 52.4% of the entire market.
Treatment-wise, the kidney stone market consists medications, extracorporeal shock wave lithotripsy (ESWL), ureteroscopy (URS), and percutaneous nephrolithotomy (PCNL). URS has the lead and can reach a worth of USD 989.9 million over the review period.
Diagnosis-based segmentation of the kidney stone market comprises ultrasound, intravenous pyelography (IVP) or intravenous urogram, CT scan and X-ray. Ultrasound leads the market with 38.6% of the market share in 2015 and expects to reach a valuation for USD 1101.6 million.
The global kidney stone market can be split for better analysis into regions of North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
North America had the largest market share of 43.9% in 2015. The sector, in the region, banks mostly on the superior healthcare infrastructure. North America, along with South America, is expected to reach USD 1243.3 million by 2022.
Browse Complete 90 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/kidney-stones-market-1745
Europe is the second largest market globally and is the fastest growing market. Rapidly increasing investment in research & development and the availability of minimally invasive treatments are reasons triggering the growth of the regional market.
The APAC has China as a significant contributor which claims almost 30.1% of the entire market share and its valuation can reach USD 155.9 million by 2022.
The MEA market expects poor growth due to the presence of several economically underdeveloped countries and lack of infrastructure. However, governments have extended their hands to provide better facilities and improve the healthcare structure.
The key players in kidney stone market are C.R. Bard Inc., E.M.S. Electro Medical Systems S.A., Cook Medical Inc., DirexGroup, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc., Boston Scientific Corp., Medispec Ltd., Siemens Ltd., Olympus Corp., Richard Wolf GmbH, Convergent Laser Technologies, STORZ MEDICAL AG, Stryker Corp., and others.
Oxalo Therapeutics, a startup from the University of Chicago is developing a peptide-based pill, which as promised can prevent the growth of kidney stones by minimalizing the oxalate content in blood and urine.
In February 2018, researchers from Murdoch University declared that they had developed a new computer modeling that by analyzing biochemical conditions can predict kidney stones.
Check Discount at https://www.marketresearchfuture.com/check-discount/1745
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312